Cumberland Pharmaceuticals (CPIX) Balance Sheet: Assets & Liabilities

Cumberland Pharmaceuticals (CPIX) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Cumberland Pharmaceuticals reported total assets of $76.82M and total liabilities of $52.28M. Shareholders' equity was $24.88M, up 10.4% from $22.55M a year earlier. Total debt stood at $10.18M against $11.44M in cash and short-term investments, a net cash position of $1.26M. That puts debt-to-equity at 0.41, compared with 0.69 a year earlier.

Cumberland Pharmaceuticals Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Cumberland Pharmaceuticals Inc. (CPIX) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	11.44	17.96	18.32	19.76	27.04	24.75	28.21	27.94	45.41
Short-Term Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	8.29	4.67
Cash & Short-Term Investments	11.44	17.96	18.32	19.76	27.04	24.75	28.21	36.23	50.09
Accounts Receivable	16.94	11.70	9.76	13.16	6.88	12.38	7.86	7.84	8.40
Inventory	6.23	4.00	4.61	9.86	8.43	10.64	8.87	27.83	6.74
Other Current Assets	2.45	2.79	3.03	3.08	3.34	2.20	5.22	2.96	3.47
Total Current Assets	37.06	36.45	35.71	45.87	45.69	49.97	50.16	74.87	68.68
Non-Current Assets
Property, Plant & Equipment (Net)	8.61	6.45	7.04	5.50	1.47	2.60	3.71	0.77	0.53
Long-Term Investments	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Goodwill	0.91	0.91	0.91	0.91	0.88	0.88	0.88	0.78	0.00
Intangible Assets	14.03	17.97	22.61	30.59	23.95	28.12	30.92	33.66	21.44
Other Non-Current Assets	12.23	13.79	15.50	10.05	12.47	14.89	18.85	2.53	2.49
Total Non-Current Assets	39.76	39.13	46.06	47.05	38.77	46.49	54.39	37.83	24.55
Total Assets	76.82	75.58	81.78	92.93	84.46	96.46	104.55	112.69	93.23
Current Liabilities
Accounts Payable	18.57	13.91	14.04	10.82	9.64	13.40	9.99	11.09	8.98
Short-Term Debt	0.47	5.46	0.35	0.17	0.97	3.20	0.92	0.00	0.00
Current Portion of Long-Term Debt	-	5.10	-	-	-	-	-	-	-
Accrued Liabilities	2.79	9.74	2.81	4.02	5.04	5.36	-	-	-
Other Current Liabilities	17.71	12.25	9.37	11.52	8.67	9.07	13.24	16.71	8.71
Total Current Liabilities	36.74	31.62	27.98	28.58	19.28	25.67	24.15	27.80	17.69
Non-Current Liabilities
Long-Term Debt	9.71	10.18	12.78	16.20	15.00	16.06	20.58	20.00	9.80
Deferred Tax Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.97	2.07
Other Non-Current Liabilities	5.82	6.30	0.27	0.13	7.49	7.86	8.74	9.32	1.82
Total Non-Current Liabilities	15.53	21.42	24.53	28.37	22.58	23.92	29.31	29.32	11.62
Total Liabilities	52.28	53.04	52.52	56.95	41.86	49.59	53.46	57.12	29.31
Stockholders' Equity
Common Stock	51.68	46.82	47.09	47.47	48.45	49.12	49.91	51.10	52.41
Retained Earnings	-26.80	-23.97	-17.49	-11.21	-5.64	-2.13	1.21	4.75	11.71
Minority Interest	-0.34	-0.31	-0.34	-0.29	-0.21	-0.12	-0.04	-0.27	-0.20
Shares Outstanding	14.96	13.95	14.12	14.37	14.74	-	-	-	-
Total Stockholders' Equity	24.88	22.55	29.60	36.27	42.60	46.99	51.12	55.84	64.12
Total Liabilities & Equity	76.82	75.58	81.78	92.93	84.46	96.46	104.55	112.69	93.23

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Cumberland Pharmaceuticals Balance Sheet

How much debt does Cumberland Pharmaceuticals have?

Cumberland Pharmaceuticals had total debt of $10.18M as of Dec 31, 2025, against $11.44M in cash and short-term investments. Its debt-to-equity ratio was 0.41. Total debt was $15.63M a year earlier.

What are Cumberland Pharmaceuticals's total assets?

Cumberland Pharmaceuticals reported total assets of $76.82M as of Dec 31, 2025, up 1.6% from $75.58M a year earlier. Total liabilities were $52.28M.

What is Cumberland Pharmaceuticals's shareholders' equity?

Cumberland Pharmaceuticals's shareholders' equity was $24.88M as of Dec 31, 2025, or about $1.66 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition